Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

NATROX Wound Care

Request full access

Portable oxygen therapy device for chronic wound healing

Cambridge, United KingdomFounded 2003Health Tech & Medtech

About NATROX Wound Care

NATROX Wound Care is a brand of the medical technology company Inotec AMD, founded in 2003 by Mel Vinton and based in Cambridge, UK. The company was established after its founder sought a solution for a family member suffering from a non-healing ulcer, leading to the development of a product that delivers oxygen to wounds. Inotec AMD focuses on creating advanced topical oxygen therapy solutions to improve healing and patients' quality of life.

The company's flagship product is NATROX® O₂, a portable, battery-powered medical device that provides continuous topical oxygen therapy (cTOT) to chronic wounds. The system consists of a small, reusable oxygen generator that extracts moisture from the air to produce 98% pure, humidified oxygen. This oxygen is delivered to the wound bed via a sterile, single-use Oxygen Delivery System (ODS) placed under a standard dressing, allowing for continuous treatment 24/7. The device is designed for use in both clinical and home care settings, treating various non-healing wounds such as diabetic foot ulcers, leg ulcers, and pressure injuries. Clinical studies have shown that NATROX® O₂ can significantly increase healing rates compared to standard care alone.

NATROX Wound Care's business model involves selling its products to healthcare providers, including the NHS in the UK and federal government departments like the Department of Veteran Affairs in the US. The company generates revenue through the sale of the disposable ODS components, while the reusable oxygen generator is often provided on loan. In some markets, particularly in Asia, NATROX is launching "NATROX® Wound Solutions," a subscription-based service that provides primary care facilities with a complete toolkit for wound care, including training, products, and diagnostics. The company has secured significant funding to support its growth, including a $33 million Series C round in late 2024 to accelerate its expansion and secure national reimbursement in the United States. The company has also brought its manufacturing in-house to manage supply and quality.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2003
Headquarters
Cambridge, United Kingdom
Employees
30
Open positions
None listed
Dealroom signal
64.9/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Spinout, wound care, DT and LS, rio ai health, rio AI medical devices, uk rio, uk is8 life sciences, UKSU
Technology
Hardware, Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Dec 2024 $33M $132M Amadeus Capital Partners · Meltwind · Puhua Capital · Wealth Club ↗
SERIES C✓Equity / VC Mar 2021 $4.9M $46M Wealth Club —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

NATROX Wound Care website traffic

Latest recorded traffic for NATROX Wound Care is 0 monthly website visits. NATROX Wound Care's team declined 16.7% over the past year.

Latest monthly visits0 1-year team growth-16.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

NATROX Wound Care in the Cambridge ecosystem

Live from Dealroom

The NATROX Wound Care office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Series B and later4 investors entered at this stage

  • Praetura Ventures
  • Wealth Club
  • Meltwind
  • Puhua Capital

Other known investors5 additional known investors

  • Cambridge Enterprise
  • University of Cambridge
  • PXN Group
  • TechWald Holding
  • University of Bristol Enterprise Fund
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States56%
🇬🇧 United Kingdom44%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about NATROX Wound Care on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See NATROX Wound Care’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.